AADI vs. CPRX

Last updated Jun 4, 2026

AADI (Aadi Bioscience, Inc.) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, AADI returned -31.30%/yr vs 41.68%/yr for CPRX. At a 0.20 correlation, their price movements are largely independent.

Performance

AADI vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aadi Bioscience, Inc. (AADI) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AADI achieves a 79.34% return, which is significantly higher than CPRX's 34.02% return.

AADI

• 1D: 3.83%
• 1M: 4.33%
• YTD: 79.34%
• 6M: 93.75%
• 1Y: 155.29%
• 3Y*: -18.64%
• 5Y*: -31.30%
• 10Y*: —

CPRX

• 1D: 0.03%
• 1M: 8.09%
• YTD: 34.02%
• 6M: 35.41%
• 1Y: 25.57%
• 3Y*: 39.39%
• 5Y*: 41.68%
• 10Y*: 48.24%

*Multi-year figures are annualized to reflect compound growth (CAGR)

AADI vs. CPRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
AADI Aadi Bioscience, Inc.	79.34%	-23.30%	56.19%	-84.26%	-46.87%	64.29%	57.05%	-63.29%	-64.21%	-20.83%
CPRX Catalyst Pharmaceuticals, Inc.	34.02%	11.84%	24.15%	-9.62%	174.74%	102.69%	-10.93%	95.31%	-50.90%	35.29%

Correlation

The correlation between AADI and CPRX is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (All Time) Calculated using the full available price history since Aug 9, 2017	0.20

Fundamentals

Market Cap AADI : $300.49M CPRX : $3.97B
EPS AADI : -$0.56 CPRX : $1.74
PB Ratio AADI : 2.59 CPRX : 3.92
Total Revenue (TTM) AADI : $0.00 CPRX : $596.96M
Gross Profit (TTM) AADI : $0.00 CPRX : $378.23M
EBITDA (TTM) AADI : -$120.90M CPRX : $313.50M

Return for Risk

AADI vs. CPRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AADI

AADI Risk / Return Rank: 88
AADI Sharpe Ratio Rank: 87
AADI Sortino Ratio Rank: 85
AADI Omega Ratio Rank: 83
AADI Calmar Ratio Rank: 94
AADI Martin Ratio Rank: 92

CPRX

CPRX Risk / Return Rank: 60
CPRX Sharpe Ratio Rank: 65
CPRX Sortino Ratio Rank: 59
CPRX Omega Ratio Rank: 59
CPRX Calmar Ratio Rank: 60
CPRX Martin Ratio Rank: 57

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AADI vs. CPRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aadi Bioscience, Inc. (AADI) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AADI	CPRX	Difference
Sharpe ratio: Return per unit of total volatility	1.98	0.76	+1.22
Sortino ratio: Return per unit of downside risk	2.73	1.25	+1.48
Omega ratio: Gain probability vs. loss probability	1.34	1.16	+0.18
Calmar ratio: Return relative to maximum drawdown	6.20	0.94	+5.26
Martin ratio: Return relative to average drawdown	14.45	1.71	+12.73
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AADI vs. CPRX - Sharpe Ratio Comparison

The current AADI Sharpe Ratio is 1.98, which is higher than the CPRX Sharpe Ratio of 0.76. The chart below compares the historical Sharpe Ratios of AADI and CPRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	AADI	CPRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.98	0.76	+1.22
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.39	0.88	-1.27
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.80	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.34	0.09	-0.43

Drawdowns

AADI vs. CPRX - Drawdown Comparison

The maximum AADI drawdown since its inception was -98.67%, roughly equal to the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for AADI and CPRX.

Drawdown Indicators

	AADI	CPRX	Difference
Max Drawdown Largest peak-to-trough decline	-98.67%	-94.25%	-4.42%
Max Drawdown (1Y) Largest decline over 1 year	-25.19%	-27.29%	+2.10%
Max Drawdown (3Y) Largest decline over 3 years	-83.90%	-27.29%	-56.61%
Max Drawdown (5Y) Largest decline over 5 years	-96.85%	-45.37%	-51.48%
Max Drawdown (10Y) Largest decline over 10 years	—	-64.87%	—
Current Drawdown Current decline from peak	-95.62%	-0.16%	-95.46%
Average Drawdown Average peak-to-trough decline	-80.46%	-52.05%	-28.41%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.79%	14.95%	-4.16%

Volatility

AADI vs. CPRX - Volatility Comparison

Aadi Bioscience, Inc. (AADI) has a higher volatility of 31.53% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 6.81%. This indicates that AADI's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AADI	CPRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	31.53%	6.81%	+24.72%
Volatility (6M) Calculated over the trailing 6-month period	53.64%	23.58%	+30.06%
Volatility (1Y) Calculated over the trailing 1-year period	78.80%	33.60%	+45.20%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	80.68%	47.86%	+32.82%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	86.13%	60.61%	+25.52%

Dividends

AADI vs. CPRX - Dividend Comparison

Neither AADI nor CPRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both AADI and CPRX in my portfolio?

AADI and CPRX have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, AADI or CPRX?

AADI has higher volatility (31.53%) compared to CPRX (6.81%). In terms of maximum drawdown, AADI dropped -98.67% vs CPRX's -94.25%.

Which has better risk-adjusted returns?

AADI currently has the higher Sharpe Ratio (1.98 vs 0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.